NCT00002131View on ClinicalTrials.gov

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Vesnarinone

Trial Locations (2)

60611

Northwestern Univ Med School, Chicago

900121973

UCLA School of Medicine, Los Angeles

Sponsors
All Listed Sponsors
lead

Otsuka America Pharmaceutical

INDUSTRY